Ac-rC Phosphoramidite

CAS No. 121058-88-6

Ac-rC Phosphoramidite( —— )

Catalog No. M28081 CAS No. 121058-88-6

Ac-rC Phosphoramidite can modify phosphodisulfide oligonucleotides.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 27 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ac-rC Phosphoramidite
  • Note
    Research use only, not for human use.
  • Brief Description
    Ac-rC Phosphoramidite can modify phosphodisulfide oligonucleotides.
  • Description
    Ac-rC Phosphoramidite can modify phosphodisulfide oligonucleotides.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Nucleoside Antimetabolite/Analog
  • Recptor
    A1|A2|A3
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    121058-88-6
  • Formula Weight
    902.114
  • Molecular Formula
    C47H64N5O9PSi
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (110.85 mM)
  • SMILES
    COc1ccc(cc1)C(OC[C@@H]1O[C@@H]([C@@H](O[Si](C)(C)C(C)(C)C)[C@H]1OP(OCCC#N)N(C(C)C)C(C)C)n1ccc(NC(C)=O)nc1=O)(c1ccccc1)c1ccc(OC)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Tchilibon S, et al. Exploring distal regions of the A3 adenosine receptor binding site: sterically constrained N6-(2-phenylethyl)adenosine derivatives as potent ligands. Bioorg Med Chem. 2004 May 1;12(9):2021-34.
molnova catalog
related products
  • Sangivamycin

    Sangivamycin is an effective inhibitor of protein kinase C (PKC, Ki = 10 μM). Sangivamycin exhibits antiproliferative activity against a variety of human cancers.

  • Aspacytarabine

    Aspacytarabine (Astarabine, BST236) is a cytarabine conjugate that shows anti-?neoplastic agents for inhibiting cancer cell growth.

  • 3-Deazauridine

    3-Deazauridine is a structural analog of uridine that inhibits the biosynthesis of Cytidine-5'-Triphosphate by competitive inhibition of Cytidine Triphosphate synthetase which is considered to be the primary mode of action of this nucleoside analog.